Description: Vivos Therapeutics Inc. is a medical technology company focused on the development and commercialization of a highly differentiated technology offering a clinically effective non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). We believe our products and technology represent a significant improvement in the treatment of mild-to-moderate OSA versus other treatments such as continuous positive airway pressure (or CPAP).
Home Page: vivos.com
VVOS Technical Analysis
9137 Ridgeline Boulevard
Highlands Ranch,
CO
80129
United States
Phone:
866 908 4867
Officers
| Name | Title |
|---|---|
| Mr. R. Kirk Huntsman | Co-Founder, Chairman & CEO |
| Mr. Bradford K. Amman | CFO, Treasurer & Sec. |
| Mr. Todd Huntsman | Co-Founder & Sr. VP of Product and Technology |
| Ms. RaeAnn Byrnes | Co-Founder and Sr. VP of Events & Clinical Advisory Services |
| Ms. Susan McCullough | Co-Founder & Exec. VP |
| Ms. Julie Gannon | Chief of Staff & Investor Relations |
| Mr. Nicholas M. DeGennaro | Sr. VP of the Medical Integration Division |
| Ms. Ruth Hembree | Sr. VP of Practice Services |
| Ms. Stephanie Huebner | Sr. VP of DSO Operations |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4303 |
| Price-to-Sales TTM: | 0.4695 |
| IPO Date: | 2020-12-11 |
| Fiscal Year End: | December |
| Full Time Employees: | 170 |